ArticleMolecular pharmaceutics2019

p53-Bad: A Novel Tumor Suppressor/Proapoptotic Factor Hybrid Directed to the Mitochondria for Ovarian Cancer Gene Therapy.

Phong Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.